Left ventricular hypertrophy

References

• Savage DD, Garrison RJ, Kannel WB, et al. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation 1987: 75(1 Pt 2): I26–33
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Messerli FH, Garavaglia GE, et al. Dietary salt intake: a determinant of cardiac involvement in essential hypertension. Circulation 1988: 78(4): 951–6
   PubMed Web of Science ®Google Scholar
• Hammond IW, Devereux RB, Alderman MH, et al. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol 1988: 12(4): 996–1004
   PubMed Web of Science ®Google Scholar
• Hammond IW, Devereux RB, Alderman MH, et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986: 7(3): 639–50
   PubMed Web of Science ®Google Scholar
• Aronow WS, Epstein S, Koenigsberg M. Usefulness of echocardiographic left ventricular hypertrophy and silent ischemia in predicting new cardiac events in elderly patients with systemic hypertension or coronary artery disease. Angiology 1990: 41(3)
   PubMed Web of Science ®Google Scholar
• Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiography and electrocardiographic findings. Circulation 1981: 63(6): 1391–8
   PubMed Web of Science ®Google Scholar
• Levy D, Savage DD, Garrison RJ, et al. Echocardiography criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987: 59(9): 956–60
   PubMed Web of Science ®Google Scholar
• Aronow WS, Schwartz KS, Koenigsberg M. Value of five electrocardiographic criteria correlated with echocardiography left ventricular hypertrophy in elderly patients. Am J Noninvas Cardiol 1987: 1(3): 1524
   Google Scholar
• Romhilt DW, Estes EH Jr. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 1968: 75(6): 752–8
   PubMed Web of Science ®Google Scholar
• Casale PN, Devereux RB, Kligfield P, et al. Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol 1985: 6(3): 572–80
   PubMed Web of Science ®Google Scholar
• Borhani NO, Blaufox MD, Oberman A, et al. Incidence of coronary heart disease and left ventricular hypertrophy in the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis 1986: 29(3 Suppl 1): 55–62
   PubMed Web of Science ®Google Scholar
• MacMahon S, Collins G, Rautaharju P, et al. Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor intervention Trial. Am J Cardiol 1989: 63(3): 202–10
   PubMed Web of Science ®Google Scholar
• Aronow WS, Koenigsberg M, Schwartz KS. Usefulness of echocardiography and electrocardiographic left ventricular hypertrophy in predicting new cardiac events and atherothrombotic brain infarction in elderly patients with systemic hypertension or coronary artery disease. Am J Noninvas Cardiol 1989: 3(6): 367–70
   Google Scholar
• Messerli FH, Ventura HO, Elizardi DJ, et al. Hypertension and sudden death: increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 1984: 77(1): 18–22
   PubMed Web of Science ®Google Scholar
• Levy D, Anderson KM, Savage DD, et al. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987: 60(7): 560–5
   PubMed Web of Science ®Google Scholar
• Aronow WS, Epstein S, Schwartz KS, et al. Correlation of complex ventricular arrhythmias detected by ambulatory electrocardiographic monitoring with echocardiography left ventricular hypertrophy in persons older than 62 years in a long-term health care facility. Am J Cardiol 1987: 60(8): 730–2
   PubMed Web of Science ®Google Scholar
• Kannel WB, Dannenberg AL, Levy D. Population implications of electrocardiographic left ventricular hypertrophy. Am J Cardiol 1987: 60(17): 85–931
   PubMed Web of Science ®Google Scholar
• Boden WE, Kleiger RE, Schechtman KB, et al. Clinical significance and prognostic importance of left ventricular hypertrophy in non-Q-wave acute myocardial infarction. Am J Cardiol 1988: 62(13): 1000–4
   PubMed Web of Science ®Google Scholar
• Casale PN, Devereux RB, Milner M, et al. Value of echocardiography measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986: 105(2): 173–8
   PubMed Web of Science ®Google Scholar
• Levy D, Garrison RJ, Savage DD, et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med 1989: 110(2): 101–7
   PubMed Web of Science ®Google Scholar
• Aronow WS, Koenigsberg M, Schwartz KS. Usefulness of echocardiography left ventricular hypertrophy in predicting new coronary events and atherothrombotic brain infarction in patients over 62 years of age. Am J Cardiol 1988: 61(13): 1130–2
   PubMed Web of Science ®Google Scholar
• Levy D, Plehn JF, Wolf PA, et al. Left ventricular mass and risk of stroke in men. (Abstr) Circulation 1987: 76(Suppl IV): IV143
   Google Scholar
• Aronow WS, Gutstein H, Hsieh FY. Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation. Am J Cardiol 1989: 63(5): 366–7
   PubMed Web of Science ®Google Scholar
• Aronow WS, Epstein S, Koenigsberg M, et al. Usefulness of echocardiography left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden cardiac death in elderly patients. Am J Cardiol 1988: 62(16): 1124–5
   PubMed Web of Science ®Google Scholar
• Drayer JI, Gardin JM, Weber MA, et al. Changes in ventricular septal thickness during diuretic therapy. Clin Pharmacol Ther 1982: 32(3): 283–8
   PubMed Web of Science ®Google Scholar
• Messerli FH, Nunez BD, Nunez MM, et al. Hypertension and sudden death: disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrhythmias. Arch Intern Med 1989: 149(6): 1263–7
   PubMedGoogle Scholar
• Drayer JI, Gardin JM, Weber MA, et al. Cardiac muscle mass during vasodilation therapy of hypertension. Clin Pharmacol Ther 1983: 33(6): 727–32
   PubMed Web of Science ®Google Scholar
• Drayer JI, Gardin JM, Weber MA, et al. Changes in cardiac anatomy and function during therapy with alpha-methyldopa: an echocardiographic study. Curr Ther Res 1982: 32(6): 856–65
   Web of Science ®Google Scholar
• Hartford M, Wendelhag I, Berglund G, et al. Cardiovascular and renal effects of long-term antihypertensive treatment. JAMA 1988: 259(17): 2553–7
   PubMed Web of Science ®Google Scholar
• Grandi AM, Venco A, Barzizza F, et al. Effect of enalapril on left ventricular mass and performance in essential hypertension. Am J Cardiol 1989: 63(15): 1093–7
   PubMed Web of Science ®Google Scholar
• Kannel WB, D'Agostino RB, Levy D, et al. Prognostic significance of regression of left ventricular hypertrophy. Circulation 1988: (Suppl II): II89
   Google Scholar